![ECOG-ACRIN logo[19516]275×75](https://blog.ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
August 31, 2026
This phase 3 clinical trial for patients with soft tissue sarcoma is comparing chemotherapy before surgery versus surgery alone
August 31, 2026
This phase 2 clinical trial is testing two variations of the triplet combination of azacitidine, venetoclax, and gilteritinib compared to standard therapy
August 31, 2026
The latest findings in breast cancer and smoking cessation support during cancer treatment
July 31, 2026
An update on our NCTN grant award, practice-changing multiple myeloma research, a promising new lung cancer study, and highlights from the Comis Translational Science Symposium
July 31, 2026
ECOG-ACRIN’s Trial Results Summaries Project informs clinical trial participants of study findings, recognizes their vital contributions, and fosters a spirit of partnership in cancer research
July 31, 2026
This phase 2 study is evaluating ivonescimab, a novel therapy designed to target the PD-1 and VEGF pathways simultaneously
July 31, 2026
The latest findings in breast cancer, cardiotoxicity, leukemia, lung cancer, myeloma, NCI-MATCH, and smoking cessation support during cancer treatment
July 31, 2026
Timely information about research presented at medical meetings, recognition of research leaders, and more
June 29, 2026
An update on federal funding and policy developments shaping the future of cancer research
June 29, 2026
The latest findings in brain tumors, breast cancer, kidney cancer, lung cancer, Merkel cell carcinoma, and precision oncology
May 28, 2026
A recap of the Spring 2026 Group Meeting and reflections on addressing distrust in science
May 28, 2026
The latest findings in breast cancer, cardiotoxicity, leukemia in older adults, and reproductive health management for cancer patients of childbearing age